US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 264 actively recruiting studies with Arizona sites out of 264 registered in total. The busiest research areas in Arizona are Breast Cancer, Multiple Myeloma, Hematopoietic and Lymphatic System Neoplasm. Leading sponsors running trials in the state include Mayo Clinic, National Cancer Institute (NCI), University of Arizona. By stage, Arizona trials break down as Phase 1 (43), Phase 2 (72), Phase 3 (84), Phase 4 (8).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
264
Recruiting Now
264
← Back to US Map
Top Conditions in Arizona
Breast Cancer (11)Multiple Myeloma (5)Hematopoietic and Lymphatic System Neoplasm (4)Acute Myeloid Leukemia (4)Endometrial Cancer (4)Geographic Atrophy (3)Anatomic Stage II Breast Cancer AJCC v8 (3)Alzheimer Disease (3)Prostate Cancer (3)Malignant Solid Neoplasm (3)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (3)Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 264 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 264. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Multiple Myeloma, Hematopoietic and Lymphatic System Neoplasm, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT05650359 N/A
Recruiting
Study of the Use of Orthopulse Photobiomodulation
Condition
Orthodontics
Enrollment
42 pts
Location
United States
Sponsor
Biolux Technology GmbH
View Trial →
NCT06158841 Phase 3
Recruiting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standa...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Austria
Sponsor
AbbVie
View Trial →
NCT07277582 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS ...
Condition
Long QT Syndrome (LQTS) 2
Enrollment
64 pts
Location
United States
Sponsor
Thryv Therapeutics, Inc.
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06963723 N/A
Recruiting
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients Wi...
Condition
Advanced Cancer
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
Alliance Foundation Trials, LL
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
View Trial →
NCT03492151 N/A
Recruiting
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancr...
Condition
Pancreatic Cyst
Enrollment
500 pts
Location
United States
Sponsor
Ohio State University Comprehe
View Trial →
NCT06655246 Phase 1
Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gas...
Condition
Gastrointestinal Stromal Tumor (GIST)
Enrollment
157 pts
Location
United States
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
View Trial →
NCT06400472 Phase 1
Recruiting
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Condition
Ovarian Neoplasms
Enrollment
495 pts
Location
United States, Australia, France
Sponsor
Eli Lilly and Company
View Trial →
NCT05486637 EARLY_Phase 1
Recruiting
Vocal Emotion Communication With Cochlear Implants
Condition
Cochlear Hearing Loss
Enrollment
255 pts
Location
United States
Sponsor
Father Flanagan's Boys' Home
View Trial →
NCT06872684 N/A
Recruiting
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Sur...
Condition
Aneurysm
Enrollment
183 pts
Location
United States
Sponsor
Stryker Neurovascular
View Trial →
NCT06984835 N/A
Recruiting
Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolab...
Condition
Nasolabial Folds
Enrollment
126 pts
Location
United States
Sponsor
AQTIS Medical B.V.
View Trial →
NCT07222917 Phase 2
Recruiting
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Ba...
Condition
Chronic Kidney Disease and Hypertension
Enrollment
218 pts
Location
United States, Argentina, Bulgaria
Sponsor
AstraZeneca
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06524882 Phase 3
Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
Condition
Amblyopia
Enrollment
252 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07198074 Phase 3
Recruiting
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Ca...
Condition
Advanced Endometrial Carcinoma
Enrollment
255 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05564390 Phase 2
Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatmen...
Condition
Acute Myeloid Leukemia
Enrollment
2,000 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06827262 N/A
Recruiting
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Condition
Chronic Low-back Pain
Enrollment
1,500 pts
Location
United States
Sponsor
Boston Scientific Corporation
View Trial →
NCT06254924 N/A
Recruiting
Qoyangnuptu: Qoyangnuptu Intervention (QI) App
Condition
Mental Health Wellness 1
Enrollment
24 pts
Location
United States
Sponsor
Northern Arizona University
View Trial →
NCT06123988 N/A
Recruiting
Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reporte...
Condition
HER2-positive Breast Cancer
Enrollment
260 pts
Location
United States
Sponsor
University of Miami
View Trial →
NCT05898646 Phase 2
Recruiting
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Ch...
Condition
AL Amyloidosis
Enrollment
96 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
Page 3 of 11 — 264 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology